Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Enhanced sensitivity to apoptosis in Ras-transformed thyroid cells

Abstract

Ras mutations occur at high frequency in thyroid cancer. In vitro, the effects of Ras in thyroid cells are pleiotropic in that expression of activated Ras has been reported to stimulate proliferation and apoptosis. An understanding of the factors that contribute to the survival versus demise of Ras-transformed cells is essential to our understanding of the contribution of Ras to thyroid neoplasia and other cancers. Constitutive expression of oncogenic H-Ras sensitized Wistar rat thyroid (WRT) cells to apoptosis stimulated by multiple insults. When deprived of matrix attachment, Ras-transformed cells perished by apoptotic cell death at a high frequency. In contrast, parental cells were more resistant to suspension-induced cell death. Ras effects on anchorage-independent cell death were reproduced by a mutant protein that signals selectively to Raf-1, but not by mutant Ras that preferentially binds to RalGDS. Expression of a Ras mutant that selectively activates PI3K resulted in substantial protection from detachment-induced cell death. MAPK activity was increased in adherent Ras12V- and Ras12V35S-expressing cells, but abolished upon detachment. Interestingly, impaired MAPK activity was sufficient to stimulate apoptosis in adherent Ras-transformed cells, but not in parental cells. Treatment with a PI3K inhibitor also stimulated apoptosis selectively in Ras-transformed cells. These results demonstrate that constitutive expression of activated Ras elicits differential effects on the survival of thyroid cells. Moreover, Ras expression results in a greater dependence of thyroid cells on MAPK and PI3K activity for their survival.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Arscott P, Knapp J, Rymaszewski M, Barton J, Bretz J, Thompson N, Baker J . 1997 Endocrinol 138: 5019–5027

  • Avvedimento V, Monticelli A, Tramontano D, Polistina C, Nitsch L, Lauro RD . 1985 Eur. J. Biochem. 149: 467–472

  • Avvedimento VE, Musti AM, Ueffing M, Obici S, Gallo A, Sanchez M, DeBrasi D, Gottesman ME . 1991 Genes Dev. 5: 22–28

  • Berlingieri M, Akamizu T, Fusco A, Grieco M, Colletta G, Cirafici A, Ikuyama S, Kohn L, G V . 1990 Biochem. Biophys. Res. Commun. 173: 172–178

  • Bond J, Dawson T, Lemoine N, Wynford-Thomas D . 1992 Mol. Carcinogenesis 5: 129–135

  • Bond J, Wyllie F, Rowson J, Radulescu A, Wynford-Thomas D . 1994 Oncogene 9: 281–290

  • Bretz J, Rymaszewski M, Arscott PL, Myc A, Ain KB, Thompson NW, Baker Jr JR . 1999 J. Biol. Chem. 274: 23627–23632

  • Burns J, Blaydes J, Wright P, Lemoine L, Bond J, Williams E, Wynford-Thomas D . 1992 Mol. Carcinogenesis 6: 129–139

  • Cass LA, Meinkoth JL . 2000 Oncogene 19: 924–932

  • Cass LA, Summers SA, Prendergast GV, Backer JM, Birnbaum MJ, Meinkoth JL . 1999 Mol. Cell. Biol. 19: 5882–5891

  • Di Matola T, Mueller F, Fenzi G, Rossi G, Bifulco M, Marzano L, Vitale M . 2000 J. Clin. Endocrinol. Metab. 85: 1188–1193

  • Dremier S, Golstein J, Mosselmans R, Dumont JE, Galand P, Robaye B . 1994 Biochem. Biophys. Res. Comm. 200: 52–58

  • Francis-Lang H, Zannini M, Felice MD, Berlingieri M, Fusco A, Lauro RD . 1992 Mol. Cell. Biol. 12: 5793–5800

  • Frisch SM, Francis H . 1994 J. Cell. Biol. 124: 793–799

  • Fusco A, Berlinghieri MT, Fiore PPD, Portella G, Grieco M, Vecchio G . 1987 Mol. Cel. Biol. 7: 3365–3370

  • Gire V, Marshall C, Wynford-Thomas D . 1999 Oncogene 18: 4819–4832

  • Gire V, Wynford-Thomas D . 2000 Oncogene 19: 737–744

  • Gire V, Marshall C, Wynford-Thomas D . 2000 Oncogene 19: 2269–2276

  • Jeso BD, Ulianich L, Racioppi L, D'Armient F, Feliciello A, Pacifico F, Consiglio E, Formisano S . 1995 Biochem. Biophys. Res. Comm. 214: 819–824

  • Joneson T, White MA, Wigler MH, Bar-Sagi D . 1996 Science 271: 810–812

  • Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G . 1997 Nature 385: 544–548

  • Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J . 1997 EMBO. J. 16: 2783–2793

  • Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M . 1989 Cell 56: 77–84

  • Kupperman E, Wofford D, Wen W, Meinkoth JL . 1996 Endocrinol. 137: 96–104

  • Lemoine NR, Staddon S, Bond J, Wyllie FS, Shaw JJ, Wynford-Thomas D . 1990 Oncogene 5: 1833–1837

  • Li X, Lu S, Miyagi E, Katoh R, Kawaoi A . 1999 Endocrinol. 140: 5962–5970

  • Lin T, Chen Q, Howe A, Juliano R . 1997 J. Biol. Chem. 272: 8849–8852

  • Maly FE, Quilliam LA, Dorseuil O, Der CJ, Bokoch GM . 1994 J. Biol. Chem. 269: 18743–18746

  • Miller MJ, Rioux L, Prendergast GV, Cannon S, White MA, Meinkoth JL . 1998 Mol. Cell. Biol. 18: 3718–3726

  • Missero C, Pirro M, Lauro RD . 2000 Mol. Cell. Biol. 20: 2783–2793

  • Namba H, Gutman RA, Matsuo K, Alvarez A, Fagin JA . 1990 J. Clin. Endocrinol. Metab. 71: 223–229

  • Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A, Downward J . 1997 Cell 89: 457–467

  • Saavedra H, Knauf J, Shirokawa J, Wang J, Ouyang B, Elisei R, Stambrook P, Fagin J . 2000 Oncogene 19: 3948–3954

  • Shirokawa JM, Elisei R, Knauf JA, Hara T, Wang J, Saavedra HI, Fagin JA . 2000 Mol. Endo. 14: 1725–1738

  • Suarez H, Villard JD, MCaillou BS, Schlumberger M, Tubiana M, Parmentier C, Monier R . 1990 Oncogene 5: 565–570

  • Tsygankova OM, Kupperman E, Wen W, Meinkoth JL . 2000 Oncogene 19: 3609–3615

  • Tsygankova OM, Saavedra A, Rebhun JF, Quilliam LA, Meinkoth JL . 2001 Mol. Cell. Biol. 21: 1921–1929

  • Vitale M, Matola TD, Bifulco M, Casamassima A, Fenzi G, Rossi G . 1999 FEBS Lett. 462: 57–60

  • White MA, Nicolette C, Minden A, Polverino A, Aelst LV, Karin M, Wigler MH . 1995 Cell 80: 533–541

Download references

Acknowledgements

We wish to acknowledge Gregory Prendergast for technical assistance and Dr Oxana Tysgankova for helpful suggestions and comments. This work was funded by PHS grant DK55757 to J Meinkoth.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Judy L Meinkoth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheng, G., Meinkoth, J. Enhanced sensitivity to apoptosis in Ras-transformed thyroid cells. Oncogene 20, 7334–7341 (2001). https://doi.org/10.1038/sj.onc.1204928

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204928

Keywords

This article is cited by

Search

Quick links